The nucleic acid amplification market share is expected to reach an estimated value of USD 1.47 billion by 2026 at an accelerating CAGR of 7.73%.

This nucleic acid amplification market research report provides valuable insights on the post-COVID-19 impact on the market, which will help companies evaluate their business approaches. The nucleic acid amplification market report also offers information on several market vendors, including Abbott Laboratories, Becton Dickinson and Co., bioMerieux SA, Danaher Corp., Eiken Chemical Co. Ltd., F. Hoffmann La Roche Ltd., Grifols SA, Hologic Inc., Illumina Inc., LGC Ltd., Meridian Bioscience Inc., New England Biolabs Inc., Novartis AG, OptiGene Ltd., Promega Corp., Quidel Corp., Siemens AG, Tecan Group Ltd., Thermo Fisher Scientific Inc., and Ustar Biotechnologies Hangzhou Ltd. among others.

This report extensively covers nucleic acid amplification market segmentation by the following:

• Technique - Target amplification, Probe amplification, and Signal amplification
• Geography - North America, Europe, Asia, and Rest of World (ROW)

What will the Nucleic Acid Amplification Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Nucleic Acid Amplification Market Size for the Forecast Period and Other Important Statistics

Nucleic Acid Amplification Market: Key Drivers, Trends, and Challenges

The increasing research and development (R&D) activities at academic institutes and medical organizations is notably driving the nucleic acid amplification market growth, although factors such as lack of skilled workforce to handle may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the nucleic acid amplification market industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Nucleic Acid Amplification Market Driver

One of the key factors driving growth in the nucleic acid amplification market is the increasing research and development (R&D) activities at academic institutes and medical organizations. Academic institutions and medical organizations utilize nucleic acid amplification techniques to carry out research studies on applications of molecular biology, microbiology, biochemistry, immunology, genetics, and cell biology. R&D activities at academic institutes and medical organizations include bioinformatics and genome sequencing, and these academic institutes and medical organizations provide DNA sequencing services to companies. Such research studies on genome sequencing and genetics, in turn, increase the adoption of nucleic acid amplification by research laboratories. Owing to the outbreak of COVID-19 in 2020, several numerous academic institutes and medical organizations across the world conducted research studies to identify potential treatments for the disease. These institutes make use of nucleic acid amplification techniques to conduct their R&D activities.

Key Nucleic Acid Amplification Market Trend

The increasing investment in the development of new biotechnological techniques is a nucleic acid amplification market trend that is expected to have a positive impact in the coming years. In recent years, end-users such as hospitals, diagnostic centers, academic institutes, and research organizations have been increasingly opting for nucleic acid amplification for disease diagnosis. Nucleic acid amplification is highly used by end-users for the detection of molecular infectious diseases. The advent of the nucleic acid amplification technique, coupled with the development of genomics, has significantly increased the use of molecular biology enzymes, kits, and reagents for the detection of pathogenic events at the genomic level. Such rising use of nucleic acid amplification for exploring disease-related genes and management of infectious diseases is expected to positively impact the growth of the global nucleic acid amplification market.

Key Nucleic Acid Amplification Market Challenge

The lack of skilled workforce to handle will be a major challenge for the nucleic acid amplification market during the forecast period. Nucleic acid amplification needs skilled professionals such as pathologists and clinicians who can perform nucleic acid amplification tests, genotyping tests, and predisposition diagnostic tests. Their responsibilities also include understanding the underlying molecular mechanisms of diseases to treat patients according to their medical condition. Skilled professionals are required to carry out a range of routine and advanced tests in laboratory-based microbiology/virology safely and competently using standard operating procedures (SOPs). The lack of adequate training and courses on nucleic acid amplification tests available for the detection and staging of a disease is one of the prime factors limiting the number of students graduating to become laboratory technicians.

This nucleic acid amplification market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global nucleic acid amplification market as a part of the global healthcare equipment market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the nucleic acid amplification market during the forecast period.

Who are the Major Nucleic Acid Amplification Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

• Abbott Laboratories
• Becton Dickinson and Co.
• bioMerieux SA
• Danaher Corp.
• Eiken Chemical Co. Ltd.
• F. Hoffmann La Roche Ltd.
• Grifols SA
• Hologic Inc.
• Illumina Inc.
• LGC Ltd.
• Meridian Bioscience Inc.
• New England Biolabs Inc.
• Novartis AG
• OptiGene Ltd.
• Promega Corp.
• Quidel Corp.
• Siemens AG
• Tecan Group Ltd.
• Thermo Fisher Scientific Inc.
• Ustar Biotechnologies Hangzhou Ltd. 

This statistical study of the nucleic acid amplification market encompasses successful business strategies deployed by the key vendors. The nucleic acid amplification market is fragmented and the vendors are deploying growth strategies such as innovative product offerings to compete in the market.

Product Insights and News

• Abbott Laboratories - Abbott Laboratories is a public company headquartered in US. It is a global company generating $43,075 million in revenues and has around 113,000 employees. Its revenue from the global nucleic acid amplification market contributes to its overall revenues along with its other offerings, but it is not a key revenue stream for the company. 
• Abbott Laboratories - The company offers nucleic acid amplification platform namely Abbott RealTime SARS CoV 2 Amplification reagent kit. 

To make the most of the opportunities and recover from the post-COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The nucleic acid amplification market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Nucleic Acid Amplification Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the nucleic acid amplification market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for Nucleic Acid Amplification Market?

For more insights on the market share of various regions Request for a FREE sample now!

38% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for nucleic acid amplification in North America. Market growth in this region will be slower than the growth of the market in the European and Asian regions.

The presence of a large number of testing laboratories, research facilities, sub-contract laboratories, and pharmaceutical companies will facilitate the nucleic acid amplification market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

The nucleic acid amplification market witnessed a positive impact during the outbreak of COVID-19 in 2020. Nucleic acid amplification is utilized in diagnostics and drug discovery which led to an increase in demand for nucleic acid amplification. Industry players started focusing on developing digital PCR kit tests to detect COVID-19. Regulatory authorities were also extending support to approve these tests to combat the consequences of the COVID-19 outbreak. Furthermore, the demand for nucleic acid amplification such as RT-PCR increased significantly during the pandemic, and nucleic acid amplification continues to be in demand. The market witnessed several approvals and the launch of PCR kits for COVID-19 detection.

What are the Revenue-generating Technique Segments in the Nucleic Acid Amplification Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The nucleic acid amplification market share growth by the target amplification segment will be significant during the forecast period. The target amplification technique has increasingly opted for molecular biology diagnoses, which is required to carry out biotechnology research. Pharmaceutical companies are also opting for target amplification techniques to discover and develop new drugs, owing to the increasing prevalence of chronic and infectious diseases globally.  The target amplification technique is increasingly used by biotechnology and pharmaceutical companies for drug development, which, in turn, propels the global nucleic acid amplification market during the forecast period.

This report provides an accurate prediction of the contribution of all the segments to the growth of the nucleic acid amplification market size and actionable market insights on the post-COVID-19 impact on each segment.

Request for a FREE sample

What are the Key Data Covered in this Nucleic Acid Amplification Market Report?

• CAGR of the market during the forecast period 2022-2026
• Detailed information on factors that will drive nucleic acid amplification market growth during the next five years
• Precise estimation of the nucleic acid amplification market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the nucleic acid amplification market industry across North America, Europe, Asia, and Rest of World (ROW)
• A thorough analysis of the market's competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of nucleic acid amplification market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch